Aspen Pharmacare had discussed destroying its stockpile of life-saving cancer drugs in order to drive up prices by 4000%, according to a report by The Times of London.
This comes after the JSE-listed pharmaceutical company bought the rights to five cancer drugs from GlaxoSmithKline.
The company [Aspen Pharmacare] would have enjoyed a monopoly in the marketplace and was no doubt tempted to use its newly gained power to exploit its customers and reap fabulous returns for its shareholders...— Rob Worthington-Smith, FarSightFirms
FarSightFirms rates the maturity of a company’s leadership based on how it responds to material non-financial issues (material to the medium- to long-term financial sustainability of the company).
It did extensive research into Aspen Pharmacare.
The drug maker also failed to disclose its 2016 €5.2-million Italian competition authority fine for price gouging.
Is Aspen Pharmacare morally bankrupt?
The Money Show’s Bruce Whitfield interviewed Worthington-Smith.
Although Aspen Pharmacare Chairperson Kuseni Dlamini was scheduled to talk to Whitfield he decided not to come on the show when he heard what the topic of conversation was.
Listen to the interview in the audio below (and/or scroll down for quotes from it).
They [Aspen Pharmacare] make fluffy statements about caring for customers…— Rob Worthington-Smith, FarSightFirms
You can’t be cheating the marketplace.— Rob Worthington-Smith, FarSightFirms
There isn’t evidence of a moral code.— Rob Worthington-Smith, FarSightFirms
It’s important that companies stand for something.— Rob Worthington-Smith, FarSightFirms
I’d love to think Aspen Pharmacare has a communication problem [instead of an ethics one].— Rob Worthington-Smith, FarSightFirms
Enter your email address in the form below to receive a newsletter containing the most-read articles of the week from Bruce Whitfield’s The Money Show every Friday morning in your inbox.
Recommendedby NEWSROOM AI
Andy Rice knocks TUC biscuits for a tweet that seems to make fun of listeriosis.
The Money Show’s Bruce Whitfield interviews former Sars spokesperson Adrian Lackay.
The Money Show’s Bruce Whitfield interviews Norton Rose Fulbright Director in Litigation Lauren Fine.
Sleep is as vital for complex life as food, water and oxygen. Bruce Whitfield interviewed FAB Quotient's Joni Peddie.
Trofin fund manager Claudius Rostoll on why he believes these three companies are the best investments on the JSE right now.
Aspen Group released results saying the international business delivered 49% of gross revenue.
Cricket writer Neil Manthorp, says there are alleged discrepancies between the report from match referee, Jeff Crowe
AfriForum CEO Kallie Kriel says they cannot sit back while government does to this country exactly what happened in Zim.
A caller shares her frustration at the response by white people of the news that Stephen Grootes is leaving 702.
Analyst explain how expropriation of land works in the South African landscape.
Experts are at odds as to whether the orgasmic pleasure point really exists.
Immigration lawyer Gary Eisenberg explains the new rules for South Africans applying for a Schengen visa
Shabir Shaik refutes media reports that he has been subpoenaed to testify against former president Jacob Zuma.
The former principal of the school in Pinelands in Cape Town allegedly used the money for a holiday and golf membership.
Bruce Whitfield interviews Francois Janse van Rensburg, author of “Making Money through Buy-To-Let in South Africa".
Elon Musk, as you’d expect, hails from an exceptional family. Bruce Whitfield interviews his Capetonian father.